Curative Biosciences, Inc. (CBDX)

USD 0.0

(0.0%)

Market Cap (In USD)

25.78 Thousand

Revenue (In USD)

-

Net Income (In USD)

-53.19 Thousand

Avg. Volume

2.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.0015
PE
-
EPS
-
Beta Value
8.035
ISIN
US23127M1018
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Richard Damion
Employee Count
-
Website
https://curativebio.com
Ipo Date
2004-08-26
Details
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.